 This study investigated the use of umbilical cord blood plasma, UCBP, derived exosomes combined with liposomes to develop a new type of wound healing agent called hybrosomes. The results suggest that hybrosomes can increase cell proliferation and migration by up to 40 to 50 percent, depending on the dose, and also reduce inflammation in cell lines and increase wound healing related gene expression levels in dermal cells in vitro. These findings indicate that hybrosomes may be a promising alternative for wound healing treatments. This article was authored by Poland Kochak, Nass Ansel, Serli Kanikian, and others.